Fresenius Medical Care Ventures
Corporate VCBad Homburg · Seed–Late Stage · 7 people tracked
Investment thesis
FMCV makes strategic equity investments in start-ups and early-stage healthcare companies, forming partnerships that give Fresenius Medical Care access to new technologies and therapy approaches in its core and complementary businesses. It invests across multiple healthcare sectors including medical devices, pharmaceuticals, digital healthcare, and healthcare services, from seed to later stage depending on strategic fit. Beyond capital, the firm leverages Fresenius Medical Care's resources to help portfolio companies navigate the path of bringing innovation to patients.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 13 of 14 portfolio companiesHealthtech ×11Medical Devices ×10Biotech ×6Digital Health ×6Hardware ×3Deep Tech ×2AI & Machine Learning ×1IoT ×1
HQs:United States×7Switzerland×1Germany×1
Investments · 14 tracked
founders shown can be your intro path
DocGo provides mobile and virtual health services, including medical transportation for hospitals, care gap closure and longitudinal care programs for payers, and population health programs for public health departments.
Digital HealthHealthtechNew York, US
Lee Bienstock(Chief Executive Officer)Norm Rosenberg(Treasurer and Chief Financial Officer)Stephen Sugrue(Chief Compliance Officer)Bonu Kapoor(Chief Medical Officer of SteadyMD; VP of Clinical Practice & Innovation at DocGo)Hawk Newton(Chief Technology Officer)Ely D. Tendler(General Counsel)
Co-investorsAlpha Ascent Ventures Llc
Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.
BiotechHealthtechMedical DevicesMorrisville, US
Laura E. Niklason(Director)inLaura Niklason, MD, PhD(Founder)inTed Lithgow(Executive Officer)inPaul Boyer(Executive Officer)inCarrie S. Cox(Executive Officer, Director)
BoardRobert Anderson(Director)
Co-investorsFirst In VenturesOberland Capital
Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Marc Zemel(Co-Founder and CEO)Ramakrishna Mukkamala(Co-Founder)Jerry Korten(Executive Vice President)Roger Mecca(Consultative Medical Officer)inAlexander Markovic(Chief Operating Officer)
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure.
BiotechHardwareHealthtechMedical DevicesRostock, DE
Katrin Stange(Chief Executive Officer)Jan Stange(Chief Medical Officer)
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care.
Digital HealthHealthtechIoTMedical DevicesGolden, US
James Mault(Executive Officer, Director)inDavid Wang(Executive Officer, Director)inRonald Chwang(Director)Alan Meeker(Director)Larry Leisure(Director)Steve Hess(Director)
Co-investorsBose VenturesCU Healthcare Innovation FundSkyPoint Ventures
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
BiotechDeep TechMedical Devices
Mike Curtis, Ph.D.(President & Chief Executive Officer)
Co-investorsAlta PartnersAltium CapitalEisai Innovation, Inc.Khosla VenturesLux Capital
BiotechHealthtechMartinez, US
Michael DiMeo(Executive Officer)Erin Borger(Executive Officer, Director)Robert S. Ward(Executive Officer, Director)Keith McCrea(Executive Officer, Director)George Pitarra(Executive Officer, Director)Kathleen White(Executive Officer)
Co-investorsCycad Group LLC
MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.
HardwareHealthtechMedical Devices
Co-investorsALIVE Israel HealthTech FundNew Enterprise Associates (NEA)OrbiMedRA Capital
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalAdjuvant CapitalVerve Venturesredalpine
Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications.
Digital HealthHealthtechMedical DevicesIrvine, US
David J. Cuccia(Founder & Chief Technology Officer)Charlie Huiner(President & Chief Executive Officer)Amaan Mazhar(Chief Product Officer)
Co-investorsPangaea VenturesPangaea Ventures Us Inc.
SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments.
Digital HealthHealthtechMobility & Transportation
Robbins Schrader(Founder)
Co-investorsBonfire VenturesFCA Venture PartnersHDS CapitalLayout VenturesMeridian Street CapitalNew Enterprise Associates (NEA)+5 more
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)Jim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)Allen Meacham(President and Chief Executive Officer)Brad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)
Co-investorsSolas BioVentures
Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsBroadview VenturesChampel CapitalGEOC
Exits · 3
IPOs and acquisitions across the tracked portfolioDocgoNASDAQ: DCGOHumacyteNASDAQ: HUMAMemo Therapeuticsacq. by Clementia
Portfolio news
latest coverage across their companiesSafeRide Health · trysignalbase.com · Jul 28, 2026
Memo Therapeutics · investing.com · Jul 22, 2026
ExThera Medical · napavalleyregister.com · Mar 6, 2026
Frequently asked questions
- How many investments has Fresenius Medical Care Ventures made?
- Fresenius Medical Care Ventures has 14 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Fresenius Medical Care Ventures invest at?
- Fresenius Medical Care Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Fresenius Medical Care Ventures focus on?
- Fresenius Medical Care Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fresenius Medical Care Ventures located?
- Fresenius Medical Care Ventures is headquartered in Bad Homburg, DE.
- Who does Fresenius Medical Care Ventures co-invest with?
- Fresenius Medical Care Ventures most often shares deals with New Enterprise Associates (NEA), Alpha Ascent Ventures Llc, Khosla Ventures, among 32 tracked co-investors.
Media · Podcasts & interviews
from their channelResearch in Brief: Personalizing meal planning for people with chronic kidney disease
Fresenius Medical Care
Research in Brief: Why lean tissue index matters in HDF | FME
Fresenius Medical Care
Research in Brief: Immunosuppressive therapies in kidney transplant recipients | FME
Fresenius Medical Care
Research in Brief: Population Characteristics in Randomized Trials for HDF | FME
Fresenius Medical Care
Artful Resilience: Samroeng Getlim's Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
A new beginning, a future awaiting: Fatin Adibah’s Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.